BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26942878)

  • 1. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
    Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
    Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
    Su L; Han D; Wu J; Huo X
    Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOP promotes SIRT2 degradation and suppresses non-small cell lung cancer cell growth.
    Luo J; Bao YC; Ji XX; Chen B; Deng QF; Zhou SW
    Biochem Biophys Res Commun; 2017 Feb; 483(2):880-884. PubMed ID: 28073696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation.
    Wang F; Chan CH; Chen K; Guan X; Lin HK; Tong Q
    Oncogene; 2012 Mar; 31(12):1546-57. PubMed ID: 21841822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of SIRT2 levels for human non-small cell lung cancer therapy.
    Li Z; Xie QR; Chen Z; Lu S; Xia W
    Lung Cancer; 2013 Oct; 82(1):9-15. PubMed ID: 23915912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
    Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
    Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
    PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
    Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
    PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
    Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
    Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
    Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
    Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.
    Xu W; Jiang K; Shen M; Qian Y; Peng Y
    Biol Chem; 2015 Aug; 396(8):929-36. PubMed ID: 25719312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of SKP2 induces apoptosis in lung-cancer cells.
    Yokoi S; Yasui K; Iizasa T; Takahashi T; Fujisawa T; Inazawa J
    Cancer Sci; 2003 Apr; 94(4):344-9. PubMed ID: 12824902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.
    Kudo Y; Kitajima S; Ogawa I; Kitagawa M; Miyauchi M; Takata T
    Mol Cancer Ther; 2005 Mar; 4(3):471-6. PubMed ID: 15767556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
    Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
    Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol Extract of Citrus grandis 'Tomentosa' Exerts Anticancer Effects by Targeting Skp2/p27 Pathway in Non-Small Cell Lung Cancer.
    Huang D; Wu PE; Chen ZJ; Pang YC; Xu ZW; Tan J; Jiang ZH; Yang BB; Zhan R; Xu H; Liu YQ
    Mol Nutr Food Res; 2023 Sep; 67(18):e2300061. PubMed ID: 37436082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
    Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skp2 inversely correlates with p27 and tuberin in transformed cells.
    Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
    Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells.
    Zhou H; Zhou L; Guan Q; Hou X; Wang C; Liu L; Wang J; Yu X; Li W; Liu H
    Commun Biol; 2023 Aug; 6(1):805. PubMed ID: 37532777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A; Yoshino I; Kometani T; Yamaguchi M; Kameyama T; Yohena T; Maehara Y
    Cancer; 2006 Jul; 107(1):154-61. PubMed ID: 16721818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.